Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00719498 | Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study) | PHASE3 | COMPLETED | 20 | — | — | Nov 1, 2003 | Jul 1, 2004 | May 17, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| Epo-alpha | DRUG | - |
Inclusion Criteria: * Patients who have OHCA of presumed cardiac origin * Patient's who have delay between the collapse and onset of cardiopulmonary resuscitation (CPR, no flow) less that 10 minutes * Patient's who have delay between onset of CPR and return of spontaneous circulation (ROSC, low flo...